Originally Posted by
ReachHeavy
Does look game changing, production at 200,000 per month initially. If approved this IP could be licensed and everyone who wants to be immune could be before the end of the year!
BTW their stock symbol is SRNE
Their stock is already through the roof. That's actually what gives me some confidence in this one, they are an established public company in bio-tech and if they misled investors with a half-baked PR stunt they'd be in a world of hurt. They must be pretty darn sure of themselves. Might call em up and see if they're hiring.